# FACT Biomarker Subgroup Analysis

> **NCT03981029** · — · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 51 (actual)

## Conditions studied

- Pre-Eclampsia

## Interventions

- **OTHER:** 4.0mg Folic Acid received through participation in FACT (NCT01355159)
- **OTHER:** Placebo received through participation in FACT

## Key facts

- **NCT ID:** NCT03981029
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-19
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981029, "FACT Biomarker Subgroup Analysis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03981029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*